Lupin enters CDMO business, names Abdelaziz Toumi as CEO of new subsidiary

Lupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development and Manufacturing Organization (CDMO) business. Abdelaziz Toumi (Abdel), with extensive experience in biotech, pharma, and CDMO sectors across multiple continents, has been appointed as the CEO of LMS.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wCpfKX2
via IFTTT